CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

MINOCA: a heterogenous group of conditions associated with myocardial damage Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Mechanisms of Vascular Aging, A Geroscience Perspective JACC Focus Seminar Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications

Consensusolume 41, Issue 24, 21 June 2020, Pages 2313–2330

JOURNAL:Eur Heart J. Article Link

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

J Borén, MJ Chapman, RM Krauss et al. Keywords: low-density lipoprotein; ASCVD; statin; mechanisms

Full Text PDF